Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2006-10-24
2006-10-24
Wang, Shengjun (Department: 1617)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S443000, C514S448000
Reexamination Certificate
active
07125908
ABSTRACT:
The present invention provides methods of treating chronic pain in a mammal by administering to the mammal an effective amount of a selective persistent sodium channel antagonist that has at least 20-fold selectivity for persistent sodium current relative to transient sodium current.
REFERENCES:
patent: 5661035 (1997-08-01), Tsien et al.
patent: 5688830 (1997-11-01), Berger et al.
patent: 5922746 (1999-07-01), Adorante
patent: 6342379 (2002-01-01), Tsien et al.
patent: 6479498 (2002-11-01), Marquess et al.
patent: 6646012 (2003-11-01), Choi et al.
patent: 6686193 (2004-02-01), Maher et al.
patent: 6699493 (2004-03-01), Wong
patent: 6726918 (2004-04-01), Wong et al.
patent: 6756400 (2004-06-01), Chinn et al.
patent: 2002/0077097 (2002-06-01), Adorante et al.
patent: 2004/0054374 (2004-03-01), Weber et al.
patent: 2004/0137059 (2004-07-01), Nivaggioli et al.
patent: 1 182 193 (2002-02-01), None
Nielsen et al, “Solution Structure of μ-Conotoxin PIIIA, a Preferential Inhibitor of Persistent Tetrodotoxin-sensitive Sodium Channels”, The Journal of Biological Chemistry, vol. 277, No. 30, Jul. 26, 2002, pp. 27247-27255.
Database Chemcats, XP002315431.
Cervero, Fernando & Jennifer M. A. Laird,Role of Ion Channels in Mechanisms Controlling Gastrointestinal Pain Pathways, 3(6) Curr. Opin. Pharmacol. 608-612 (2003).
Black, Joel A. et al.,Changes in the Expression of Tetrodotoxin-Sensitive Sodium Channels Within Dorsal Root Ganglia Neurons in Inflammatory Pain, 108(3) PAIN 237-247 (2004).
Li, Yunru et al.,Role of Persistent Sodium and Calcium Currents in Motoneuron Firing and Spasticity in Chronic Spinal Rats, 91(2) J. Neurophysiol. 767-783 (2004).
Catterall, William A.,From Ionic Currents to Molecular Mechanism: The Structure and Function of Voltage-gated Sodium Channels, 26(1) NEURON 13-25 (2000).
Novakovic, Sanja D. et al.,Regulation of Na+Channel Distribution in the Nervous System, 24(8) Trends Neurosci. 473-478 (2001).
Taddese, Abraha & Bruce P. Bean,Subthreshold Sodium Current from Rapidly Inactivating Sodium Channels Drives Spontaneous Firing of Tubermammillary Neurons, 33(4) NEURON 587-600 (2002).
Do, Michael Tri H. & Bruce P. Bean,Subthreshold Sodium Currents and Pacemaking of Subthalamic Neurons: Modulation by Slow Inactivation, 39(1) NEURON 109-120 (2003).
Magistretti, Jacopo & Angel Alonso,Biophysical Properties and Slow-voltage Dependent Inactivation of a Sustained Sodium Current in Entorhinal Cortex Layer-II Principal Neurons: A Whole-Cell and Single-Channel Study114(4) J. Gen. Physiol. 491-509 (1999).
Stys, Peter K.,Anoxic and Ischemic Injury of Myelinated Axons in CNS White Matter: From Mechanistic Concepts to Therapeutics, 18(1) J. Cereb. Blood Flow Metab. 2-25 (1998).
Crill, Wayne E.,Persistent Sodium Current in Mammalian Central Neurons58 Annu. Rev. Physiol. 349-362 (1996).
Ragsdale, David S. & Avoli, Massimo,Sodium Channels as Molecular Targets for Antiepileptic Drugs, 26(1) Brain Res. Brain Res. Rev. 16-28 (1998).
Lossin, Christoph et al.,Molecular Basis of an Inherited Epilepsy34(6) NEURON 877-84 (2002).
Stys, Peter K. et al.,Ionic Mechanisms of Anoxic Injury in Mammalian CNS White Matter: Role of Na+Channels and Na(+)-Ca2+Exchanger, 12(2) J. Neurosci. 430-439 (1992).
Stys, Peter K. et al.,Noninactivating, Tetrodotoxin-SensitiveNa+Conductance in Rat Optic Nerve Axons, 90(15) Proc. Natl. Acad. Sci. USA, 6976-6980 (1993).
Garthwaite, Gita et al.,Mechanisms of Ischaemic Damage to Central White Matter Axons: A Quantitative Histological Analysis Using Rat Optic Nerve, 94(4) Neuroscience 1219-1230 (1999).
Baker, Mark D. & John N. Wood,Involvement of Na+Channels in Pain Pathways, 22(1) Trends Pharmacol. Sci. 27-31 (2001).
Wood, John N. et al.,Sodium Channels in Primary Sensory Neurons: Relationship to Pain States, 241 Novartis Found. Symp. 159-168 (2002).
Lai, Josephine et al.,The Role of Voltage-gated Sodium Channels in Neuropathic Pain, 13(3) Curr. Opin. Neurobiol. 291-297 (2003).
LoGrasso, Philip & Jeffrey McKelvy,Advances in Pain Therapeutics, 7(4) Curr. Opin. Chem. Biol. 452-456 (2003).
Birch, Phillip J. et al.,Strategies to Identify Ion Channel Modulators: Current and Novel Approaches to Target Neuropathic Pain, 9(9) Drug Discov. Today 410-418 (2004).
Lai, Josephine et al.,Voltage-gated sodium channels and hyperalgesia, 44 Annu. Rev. Pharmacol. Toxicol. 371-397 (2004).
Hains, Bryan C. et al.,Upregulation of Sodium Channel Nav1.3 and Functional Involvement in Neuronal Hyperexcitability Associated With Central Neuropathic Pain After Spinal Cord Injury, 23(26) J. Neurosci. 8881-8892 (2003).
Hains, Bryan C. et al.,Altered Sodium Channel Expression in Second-Order Spinal Sensory Neurons Contributes to Pain after Peripheral Nerve Injury, 24(20) J. Neurosci. 4832-4839 (2004).
Jayasena, Sumedha D.,Aptamers: An Emerging Class of Molecules That Rival Antibodies in Diagnostics, 45(9) Clin. Chem. 1628-1650 (1999).
Elbashir, Sayda M. et al.,Duplexes of 21-nucleotide RNAs Mediate RNA Interference in Cultured Mammalian Cells, 411(6836) NATURE 494-498 (2001).
Bass, B. L.,RNA Interference. The Short Answer, 411(6836) NATURE 428-429 (2001).
Zamore, Phillip D.,RNA Interference: Listening to the Sound of Silence, 8(9) Nat. Struct. Biol. 746-750 (2001).
Karabinos, Anton et al.,Essential Roles for Four Cytoplasmic Intermediate Filament Proteins in Caenorhabditis elegans Development, 98(14) Proc. Natl. Acad. Sci. USA 7863-7868 (2001).
Sakmann, Bert & Erwin Neher, Single Channel Recording (Plenum Press, 2nded. 1995).
Shih, Tsung-Ming et al.,High-level Expression and Detection of Ion Channels in Xenopus Oocytes, 529-556 (Methods in Enzymology: Ion Channels Part B, vol. 293, P. Michael Conn ed., Academic Press 1998).
Johnson, Iain D.,Fluorescent Probes for Living Cells30(3) Histochem. J. 123-140 (1998).
Imaging Neurons: A Laboratory Manual (Rafael Yuste, et al., eds., Cold Spring Harbor Laboratory Press, 2000).
Gonzalez, Jesus E. & Roger Y. Tsien,Improved Indicators of Cell Membrane Potential That Use Fluorescence Resonance Energy Transfer4(4) Chem. Biol. 269-277 (1997).
Gonzalez, Jesus E. & Michael P. Maher,Cellular Fluorescent Indicators and Voltage/Ion Probe Reader(VIPR)Tools for Ion Channel and Receptor Drug Discovery, 8(5-6) Receptors Channels 283-295, (2002)
Molecular Cloning a Laboratory Manual (Joseph Sambrook & David W. Russell eds., Cold Spring Harbor Laboratory Press, 3rded. 2001).
Current Protocols in Molecular Biology (Frederick M. Ausubel et al., eds., John Wiley & Sons, 2004).
Goldin, Alan L.,Diversity of Mammalian Voltage-gated Sodium Channels, 868 Ann. N.Y. Acad. Sci. 38-50 (1999).
Wood, John N. & Mark D. Baker,Voltage-gated Sodium Channels, 1(1) Curr. Opin. Pharmacol. 17-21 (2001).
Yu, Frank H. & William A. Catterall,Overview of the Voltage-Gated Sodium Channel Family, 4(3) Genome Biol. 207 (2003).
GenBank database (National Institutes of Health, National Library of Medicine, http://www.ncbi.nlm.nih.gov/).
Koster, R. et al.,Acetic Acid for Analgesic Screening, 18 FED. Proc. 412-416 (1959).
Dewey, William L. et al.,The Effect of Narcotics and Narcotic Antagonists on the Tail-Flick Response in Spinal Mice, 21(8) J. Pharm. Pharmacol. 548-550 (1969).
Kim, Sun H. & Jin M. Chung,An Experimental Model for Peripheral Neuropathy Produced by Segmental Spinal Nerve Ligation in the Rat, 50(3) PAIN 355-363 (1992).
Bennett, Gary J. and Yi-Kuan Xie,A Peripheral Mononeuropathy in Rat That Produces Disorders of Pain Sensation Like Those Seen in Man, 33(1) PAIN 87-107 (1988).
Lee, Youn-Woo et al.,Systemic and Supraspinal, but not Spinal, Opiates Suppress Allodynia in a Rat Neuropathic Pain Model, 199(2) Neurosci. Lett. 186:111-114 (1995).
Malmberg, Annika B. & Tony L. Yaksh,Antinociceptive Actions of Spinal Nonsteroidal Anti-Inflammatory Agents on the Formalin Test in the Rat, 263(1) J. Pharmacol. Exp. Ther. 136-146 (1992).
Kirk, Roger E., Experimental Design: Procedures for the Behavioral Sciences, (Wadsworth Publishing, 3rded. 1994).
Pharmaceutical Dosage Forms and Drug Delivery Systems (Howar
Adorante Joseph S.
Donello John E.
Ehring George R.
Malone Thomas
Wheeler Larry A.
Allergan Inc.
Baran Robert J.
Chong Yong S.
Stathakis Dean G.
Voet Martin A.
LandOfFree
Treating pain using selective antagonists of persistent... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Treating pain using selective antagonists of persistent..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treating pain using selective antagonists of persistent... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3661831